Anti-psychotic Medications Offer New Hope in the Battle Against Glioblastoma
Researchers at the University of California, San Diego School of Medicine have discovered that FDA-approved anti-psychotic drugs possess tumor-killing activity against the most aggressive form of primary brain cancer, glioblastoma.